Twitxy
Saved
@LungPrc's profile picture
View on X

lungPRC

@LungPrc

We are a research consortium studying the delivery of lung cancer screening and associated outcomes. Posts on this page do not reflect the opinions of the NIH.
Joined July 2021
17 Following 32 Followers 33 Posts

Latest posts 5

lungPRC @LungPrc
Excited to share our consortium's latest publication led by @kate_rendle on downstream procedures and complications following #lungcancer screening!
@AnnalsofIM
acpjournals.org/doi/10.7326/M2…
www.acpjournals.org Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine... Background: Lung cancer screening (LCS) using low-dose computed tomography (LDCT) reduces lung cancer mortality but can lead to downstream procedures, complications, and other potential harms....
lungPRC @LungPrc
A new LOTUS publication is now available online at @MedicalCareLWW! Kris Wain and team looked at lung cancer screening utilization among cohort members enrolled in health plans with deductibles. pubmed.ncbi.nlm.nih.gov/37582296/#:~:t….
pubmed.ncbi.nlm.nih.gov Individuals Eligible for Lung Cancer Screening Less Likely to Receive Screening When Enrolled in... These findings suggest individuals enrolled in deductible plans are more likely to forgo preventive LCS services despite requiring no out-of-pocket costs. This result may indicate that increased...
lungPRC @LungPrc
@dpritzwoller Was interviewed by @USATODAYhealth about the importance of #lungcancerscreening and the challenges with its implementation across the US healthcare system. Read her powerful personal story here:
usatoday.com/story/news/hea…
www.usatoday.com Lung cancer screening saves lives. So why do so few of those at risk get one? New study finds less than 6% of those eligible get lung cancer screenings. Experts point to complicated guidelines, lack of awareness, wary patients.
lungPRC @LungPrc
Congratulations to our PROSPR partners and LOTUS authors for their recent publication in @AnnalsofIM! Here is the link to their article: acpjournals.org/doi/10.7326/M2…
@NikkiMCarroll1 @AnilVachani @kate_rendle @RitzwollerDebra @NCICareDelivRes @JulSteSte
www.acpjournals.org Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines | Annals of Internal Medicine Background: Cancer screening should be recommended only when the balance between benefits and harms is favorable. This review evaluated how U.S. cancer screening guidelines reported harms, within and...
Annals of Int Med Verified account @AnnalsofIM Sep 26, 2022
The latest from Annals of Internal Medicine is online now. Check out new research on ADR requirements for colonoscopies for FIT-positive persons, harms reporting in cancer guidelines, and more: acpjournals.org/latest/aim
View quoted post on X